Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Bidrar overdiagnostikk til høye melanomtall?

Kristiansen IS, Bugge C, Førde OH.

Tidsskr Nor Laegeforen. 2018 Jun 26;138(11). doi: 10.4045/tidsskr.17.0600. Print 2018 Jun 26. Norwegian. No abstract available.

PMID:
29947202
Free Article
2.

Priority-setting in the patients' last years of life.

Kristiansen IS, Bugge C.

Tidsskr Nor Laegeforen. 2018 May 28;138(9). doi: 10.4045/tidsskr.18.0389. Print 2018 May 29. Norwegian, English. No abstract available.

3.

Factors affecting continuation of clean intermittent catheterisation in people with multiple sclerosis: Results of the COSMOS mixed-methods study.

McClurg D, Bugge C, Elders A, Irshad T, Hagen S, Moore KN, Buckley B, Fader M.

Mult Scler. 2018 Apr 1:1352458518768722. doi: 10.1177/1352458518768722. [Epub ahead of print]

PMID:
29683042
4.

Sufficiency and relevance of information for inpatients in general ward settings: A qualitative exploration of information exchange between patients and nurses.

Crispin V, Bugge C, Stoddart K.

Int J Nurs Stud. 2017 Oct;75:112-122. doi: 10.1016/j.ijnurstu.2017.07.010. Epub 2017 Jul 22.

PMID:
28783488
5.

A nurse-led education and cognitive behaviour therapy-based intervention among adults with uncontrolled type 2 diabetes: A randomised controlled trial.

Whitehead LC, Crowe MT, Carter JD, Maskill VR, Carlyle D, Bugge C, Frampton CMA.

J Eval Clin Pract. 2017 Aug;23(4):821-829. doi: 10.1111/jep.12725. Epub 2017 Apr 11.

PMID:
28397334
6.

Living with sub-optimal glycaemic control: the experiences of Type 2 diabetes diagnosis and education.

Crowe M, Whitehead L, Bugge C, Carlyle D, Carter J, Maskill V.

J Adv Nurs. 2017 Mar;73(3):612-621. doi: 10.1111/jan.13145. Epub 2016 Sep 28.

PMID:
27624181
7.

A nurse-led interdisciplinary approach to promote self-management of type 2 diabetes: a process evaluation of post-intervention experiences.

Whitehead LC, Crowe MT, Carter JD, Maskill VR, Carlyle D, Bugge C, Frampton CM.

J Eval Clin Pract. 2017 Apr;23(2):264-271. doi: 10.1111/jep.12594. Epub 2016 Jul 15.

PMID:
27417302
8.

Caring for continence in stroke care settings: a qualitative study of patients' and staff perspectives on the implementation of a new continence care intervention.

Brady MC, Jamieson K, Bugge C, Hagen S, McClurg D, Chalmers C, Langhorne P.

Clin Rehabil. 2016 May;30(5):481-94. doi: 10.1177/0269215515589331. Epub 2015 Jun 4.

PMID:
26048436
9.

Commercial gaming devices for stroke upper limb rehabilitation: a survey of current practice.

Thomson K, Pollock A, Bugge C, Brady MC.

Disabil Rehabil Assist Technol. 2016 Aug;11(6):454-61. doi: 10.3109/17483107.2015.1005031. Epub 2015 Jan 30.

PMID:
25634339
10.

Nanoscale three-dimensional imaging of the human myocyte.

Sulkin MS, Yang F, Holzem KM, Van Leer B, Bugge C, Laughner JI, Green K, Efimov IR.

J Struct Biol. 2014 Oct;188(1):55-60. doi: 10.1016/j.jsb.2014.08.005. Epub 2014 Aug 23.

11.

Deletion of aquaporin-4 increases extracellular K(+) concentration during synaptic stimulation in mouse hippocampus.

Haj-Yasein NN, Bugge CE, Jensen V, Østby I, Ottersen OP, Hvalby Ø, Nagelhus EA.

Brain Struct Funct. 2015 Jul;220(4):2469-74. doi: 10.1007/s00429-014-0767-z. Epub 2014 Apr 18.

12.

Commercial gaming devices for stroke upper limb rehabilitation: a systematic review.

Thomson K, Pollock A, Bugge C, Brady M.

Int J Stroke. 2014 Jun;9(4):479-88. doi: 10.1111/ijs.12263. Epub 2014 Mar 24. Review.

PMID:
24661797
13.

The new clinical leadership role of senior charge nurses: a mixed methods study of their views and experience.

Stoddart K, Bugge C, Shepherd A, Farquharson B.

J Nurs Manag. 2014 Jan;22(1):49-59. doi: 10.1111/jonm.12008. Epub 2012 Nov 1.

PMID:
27531199
14.

A process for Decision-making after Pilot and feasibility Trials (ADePT): development following a feasibility study of a complex intervention for pelvic organ prolapse.

Bugge C, Williams B, Hagen S, Logan J, Glazener C, Pringle S, Sinclair L.

Trials. 2013 Oct 25;14:353. doi: 10.1186/1745-6215-14-353.

15.

Pessaries (mechanical devices) for pelvic organ prolapse in women.

Bugge C, Adams EJ, Gopinath D, Reid F.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004010. doi: 10.1002/14651858.CD004010.pub3. Review.

PMID:
23450548
16.

Vaginal pessaries for pelvic organ prolapse and urinary incontinence: a multiprofessional survey of practice.

Bugge C, Hagen S, Thakar R.

Int Urogynecol J. 2013 Jun;24(6):1017-24. doi: 10.1007/s00192-012-1985-7. Epub 2012 Nov 21.

PMID:
23179500
17.

Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.

Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E, Kwon-Chung KJ.

FEMS Yeast Res. 2012 Nov;12(7):748-54. doi: 10.1111/j.1567-1364.2012.00824.x. Epub 2012 Jul 18.

18.

Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans.

Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E, Kwon-Chung KJ.

PLoS One. 2012;7(3):e33022. doi: 10.1371/journal.pone.0033022. Epub 2012 Mar 7.

19.

Uncovering the features of negotiation in developing the patient-nurse relationship.

Stoddart K, Bugge C.

Br J Community Nurs. 2012 Feb;17(2):77-80, 82-4.

PMID:
22306600
20.

Engagement: an indicator of difference in the perceptions of antenatal care for pregnant women from diverse socioeconomic backgrounds.

Docherty A, Bugge C, Watterson A.

Health Expect. 2012 Jun;15(2):126-38. doi: 10.1111/j.1369-7625.2011.00684.x. Epub 2011 May 25.

21.

How people present symptoms to health services: a theory-based content analysis.

Farquharson B, Johnston M, Bugge C.

Br J Gen Pract. 2011 Apr;61(585):267-73. doi: 10.3399/bjgp11X567090.

22.

Psychometric properties of the pelvic organ prolapse symptom score.

Hagen S, Glazener C, Sinclair L, Stark D, Bugge C.

BJOG. 2009 Jan;116(1):25-31. doi: 10.1111/j.1471-0528.2008.01903.x. Epub 2008 Oct 8.

23.

Acute respiratory pathology in newborns and infants.

Barberi I, Tulino V, Buggè C, Gitto E.

Pediatr Med Chir. 2005 Sep-Oct;27(5):30-2. No abstract available.

PMID:
16913625
24.
25.

The significance for decision-making of information that is not exchanged by patients and health professionals during consultations.

Bugge C, Entwistle VA, Watt IS.

Soc Sci Med. 2006 Oct;63(8):2065-78. Epub 2006 Jun 21.

PMID:
16790305
26.

Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment.

Gitto E, Reiter RJ, Sabatino G, Buonocore G, Romeo C, Gitto P, Buggé C, Trimarchi G, Barberi I.

J Pineal Res. 2005 Oct;39(3):287-93.

PMID:
16150110
27.

Assessing patients' participation and quality of decision-making: insights from a study of routine practice in diverse settings.

Entwistle VA, Watt IS, Gilhooly K, Bugge C, Haites N, Walker AE.

Patient Educ Couns. 2004 Oct;55(1):105-13.

PMID:
15476997
28.

[The patient as a supplier of knowledge].

Bugge C, Falch JA.

Tidsskr Nor Laegeforen. 2004 Feb 19;124(4):513-4. Norwegian. No abstract available.

29.

The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.

Shelton MJ, Cloen D, DiFrancesco R, Berenson CS, Esch A, de Caprariis PJ, Palic B, Schur JL, Buggé CJ, Ljungqvist A, Espinosa O, Hewitt RG.

J Clin Pharmacol. 2004 Mar;44(3):293-304.

PMID:
14973306
30.

Psychometric properties of the SF-36 in the early post-stroke phase.

Hagen S, Bugge C, Alexander H.

J Adv Nurs. 2003 Dec;44(5):461-8.

PMID:
14651694
31.

Incidence, hospital admission rate, and health outcomes following stroke in Ayrshire and Arran.

Alexander H, Bugge C, Hagen S, Russell E.

Health Bull (Edinb). 2000 Sep;58(5):408-13.

PMID:
12813795
32.

What is the association between the different components of stroke rehabilitation and health outcomes?

Alexander H, Bugge C, Hagen S.

Clin Rehabil. 2001 Apr;15(2):207-15.

PMID:
11330766
33.

Measuring stroke patients' health status in the early post-stroke phase using the SF36.

Bugge C, Hagen S, Alexander H.

Int J Nurs Stud. 2001 Jun;38(3):319-27.

PMID:
11245868
34.
35.
36.

Analgesic dose-response relationship of ibuprofen 50, 100, 200, and 400 mg after surgical removal of third molars: a single-dose, randomized, placebo-controlled, and double-blind study of 304 patients.

Schou S, Nielsen H, Nattestad A, Hillerup S, Ritzau M, Branebjerg PE, Bugge C, Skoglund LA.

J Clin Pharmacol. 1998 May;38(5):447-54.

PMID:
9602959
37.

Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.

Kurz MA, Bullough DA, Buggé CJ, Mullane KM, Young MA.

Eur J Pharmacol. 1997 Mar 19;322(2-3):211-20.

PMID:
9098689
38.

A descriptive study of multidisciplinary mental health staff moving to the community: the demographic and educational issues.

Bugge C, Smith LN, Shanley E.

J Psychiatr Ment Health Nurs. 1997 Feb;4(1):45-54. Review.

PMID:
9171575
39.

A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars.

Nørholt SE, Sindet-Pedersen S, Bugge C, Branebjerg PE, Ersbøll BK, Bastian HL.

J Clin Pharmacol. 1995 Jun;35(6):606-14.

PMID:
7665721
40.

Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice.

Yuan JH, Goehl TJ, Abdo K, Clark J, Espinosa O, Bugge C, Garcia D.

Food Chem Toxicol. 1995 Feb;33(2):151-8.

PMID:
7868001
41.

Tear concentrations of topically applied ciprofloxacin.

Limberg M, Buggé C.

Cornea. 1994 Nov;13(6):496-9.

PMID:
7842707
42.

Multidisciplinary care of the mentally ill: the transfer of staff from hospital to community.

Bugge C, Smith L.

J Psychiatr Ment Health Nurs. 1994;1(1):48-9. No abstract available.

PMID:
7953800
43.

Determination of mirfentanil hydrochloride (A-3508.HCl) in human plasma by liquid chromatography-mass spectrometry.

Buggé CJ, Tucker MD, Garcia DB, Kvalo LT, Wilhelm JA.

J Pharm Biomed Anal. 1993 Sep;11(9):809-15.

PMID:
8218525
44.

Corneal stromal penetration of topical ciprofloxacin in humans.

McDermott ML, Tran TD, Cowden JW, Buggé CJ.

Ophthalmology. 1993 Feb;100(2):197-200.

PMID:
8437827
46.

Human biliary metabolites of isotretinoin: identification, quantification, synthesis, and biological activity.

Vane FM, Bugge CJ, Rodriguez LC, Rosenberger M, Doran TI.

Xenobiotica. 1990 Feb;20(2):193-207.

PMID:
2333716
47.

Identification of etretinate metabolites in human bile.

Vane FM, Buggé CJ, Rodriguez LC.

Drug Metab Dispos. 1989 May-Jun;17(3):275-9.

PMID:
2568908
48.

Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage.

Lucek RW, Dickerson J, Carter DE, Bugge CJ, Crews T, Vane FM, Cunningham W, Colburn WA.

Biopharm Drug Dispos. 1988 Sep-Oct;9(5):487-99.

PMID:
3066416
49.

Effect of meals on the kinetics of etretinate.

Colburn WA, Gibson DM, Rodriguez LC, Buggé CJ, Blumenthal HP.

J Clin Pharmacol. 1985 Nov-Dec;25(8):583-9.

PMID:
3841130
50.

Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.

Colburn WA, Vane FM, Bugge CJ, Carter DE, Bressler R, Ehmann CW.

Drug Metab Dispos. 1985 May-Jun;13(3):327-32.

PMID:
2861992

Supplemental Content

Support Center